Tag: authorising vaccines

Industry, Vaccines

Immuno-bridging studies are sufficient for authorising new COVID-19 vaccines, say regulators

September 16, 2021

Via: European Pharmaceutical Review

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced that, though placebo-controlled disease endpoint trials are the gold standard for authorising vaccines, well-justified and appropriately designed immuno-bridging studies are an acceptable approach for authorising COVID-19 vaccines. Immuno-bridging studies […]